Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

RC1 - Roller Coaster 1

Wednesday, November 13, 2024
10:45 AM – 12:15 PM MST
Location: Canyon Ballroom

Disclosure(s):
Emmanuel Chigutsa, PhD: Eli Lilly and Company: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Xiling Jiang, PhD: No financial relationships to disclose
Joga Gobburu, PhD MBA: Pumas-AI Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Vivpro Corp: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Theodore Lystig, MS, PhD: BridgeBio: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Liping Zhang, PhD: No financial relationships to disclose
Grace V. Lee, PhD: No financial relationships to disclose

Presentations:

  • 10:50 AM – 11:05 AM MST
    Use of quantitative tools to facilitate TCE development—CRS and beyond

    Speaker: Xiling Jiang, PhD – US FDA

  • 11:05 AM – 11:20 AM MST
    Transforming Healthcare with Large Language Models: Opportunities and challenges

    Speaker: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland

  • 11:20 AM – 11:35 AM MST
    Opportunities between ASA BioPharm and ISOP: Training the next generation Quantitative Scientists

    Speaker: Theodore Lystig, MS, PhD – BridgeBio

  • 11:35 AM – 11:50 AM MST
    Optimizing Dosing and Efficiency in Developing Direct Oral Anticoagulants Through Modeling-Informed Approaches

    Speaker: Liping Zhang, PhD (she/her/hers) – Johnson and Johnson

  • 11:50 AM – 12:05 PM MST
    Bridging to New Horizons in Pharmacometrics and Drug Development through Digital Health Innovation

    Speaker: Grace V. Lee, PhD (she/her/hers) – Critical Path Institute